The News Review:

- Bay area doctors test medicines of the future
- Kendle to Present at Thomas Weisel Partners Healthcare Conference 2007
- Byrd center reaches milestone Tampa Bay Business Journal
- Selling biotech involves tricky marketing calculus

Bay area doctors test medicines of the future
Bizjournals.com – Aug 31, 2007
"If you look at where cardiovascular patients are that potentially could be enrolled the majority of those patients are not seen in universities. They're in private practices. " A clinical trial can sound scary said Ashley Scheppf clinical research coordinator at. "Patients think they will be a guinea pig and they're scared so that's a barrier" she said. "But we're a small institution and less scary. It's almost like coming in for a checkup… "If you look at where cardiovascular patients are that potentially could be enrolled the majority of those patients are not seen in universities. They're in private practices. " A clinical trial can sound scary said Ashley Scheppf clinical research coordinator at. "Patients think they will be a guinea pig and they're scared so that's a barrier" she said. "But we're a small institution and less scary. It's almost like coming in for a checkup.

Kendle to Present at Thomas Weisel Partners Healthcare Conference 2007
Genetic Engineering News – Genetic Engineering News (press release) – Aug 31, 2007
com in the InvestorRelations section. About Kendle Kendle International Inc. We deliver innovative androbust clinical development solutions – from first-in-human studies throughmarket launch and surveillance – to help the world’s biopharmaceuticalcompanies maximize product life cycles and grow market share.

Byrd center reaches milestone Tampa Bay Business Journal
Bizjournals.com – Aug 31, 2007
Huntington Potter is the chief executive officer and scientific director of the Byrd Institute. The facility located at 4001 E. Tampa has 60000 square feet of laboratory research space 20000 square feet of clinical research space and 2000 square feet for education and community space. Research includes investigations into bio-chemical markers for Alzheimer's the effects of environmental enrichment on brain function the genetic link between Down syndrome and Alzheimer's and the therapeutic effects of caffeine the release said. The Florida Legislature created the Byrd center in 2002.

Selling biotech involves tricky marketing calculus
Bizjournals.com – Aug 31, 2007
Patients physicians advocacy groups and the media for example like stories about cutting-edge science for unmet medical needs. Investors prefer low-risk cost-effective strategies to reach proven markets quickly. Though companies don't talk about it as much clinical research can also be a form of marketing. If few patients have a disease a high proportion of patients and specialists might be recruited for the clinical trial and marketing and research can be done at once. Asking physicians for their opinions gives companies the chance to convince them that their product is valuable. Tailoring the message But companies can't get away with tailoring very different messages to different audiences said Jim Weiss a former senior manager of communications at Genentech who now runs a consulting firm headquartered in San Francisco. "What I tell my clients is that you can't communicate in any silo anymore.